Weight Loss Now KY

Weight Loss Now KY operates as a telehealth-focused weight management clinic serving patients throughout Kentucky from its Hurstbourne base. Under the medical direction of Dr. Henry Bohler, the practice combines obesity medicine protocols with reproductive endocrinology expertise to address weight loss through evidence-based pharmacotherapy. Dr. Bohler holds board certifications in Weight Management, Obesity Medicine, OB/GYN, and Reproductive Endocrinology and Infertility, bringing a multidisciplinary perspective to metabolic health that accounts for hormonal influences on body composition and weight regulation.

The clinic's pharmacological approach centers on two GLP-1 receptor agonist peptides: semaglutide and tirzepatide. Semaglutide functions as a glucagon-like peptide-1 analog that reduces appetite through hypothalamic signaling and slows gastric emptying, while tirzepatide operates as a dual GIP/GLP-1 receptor agonist with enhanced metabolic effects on insulin sensitivity and energy expenditure. Weight Loss Now KY prescribes these peptides as part of structured weight management programs that include dosage titration protocols, nutritional guidance, and ongoing metabolic monitoring. Patients receive individualized peptide selection based on their metabolic profile, weight loss goals, comorbid conditions such as type 2 diabetes or polycystic ovary syndrome, and tolerance to incretin-based therapies. The clinic's protocols follow current obesity medicine guidelines for peptide therapy initiation, maintenance dosing, and long-term weight maintenance strategies.

Dr. Bohler's background in reproductive endocrinology informs the clinic's approach to patients experiencing weight gain related to hormonal transitions, including perimenopause, postpartum periods, and conditions like PCOS where insulin resistance and androgen excess complicate weight management. This specialized knowledge allows Weight Loss Now KY to address the intersection of reproductive hormones and metabolic function, particularly for female patients whose weight struggles correlate with gynecological or fertility concerns. The clinic evaluates thyroid function, sex hormone levels, cortisol patterns, and insulin dynamics as part of comprehensive metabolic assessments that guide peptide therapy decisions and adjunctive interventions.

Patients engage with Weight Loss Now KY entirely through telehealth appointments, eliminating travel requirements for Kentucky residents seeking medical weight loss support. Initial consultations involve detailed medical history review, current medication assessment, discussion of previous weight loss attempts, and evaluation of contraindications to GLP-1 therapies. Dr. Bohler establishes baseline metabolic parameters and sets realistic weight loss targets based on individual circumstances. Follow-up visits occur at regular intervals to monitor peptide response, adjust dosages, manage side effects such as nausea or gastrointestinal symptoms, and provide accountability throughout the weight loss process. The virtual care model accommodates patients across Kentucky who lack local access to obesity medicine specialists or prefer the convenience of remote consultations.

Weight Loss Now KY differentiates itself through Dr. Bohler's rare combination of obesity medicine and reproductive endocrinology credentials, positioning the practice to serve patients whose weight management needs intersect with hormonal health concerns. The Hurstbourne clinic provides peptide prescriptions with pharmacy coordination, ongoing medical supervision, and metabolic guidance tailored to each patient's physiological response to treatment. For Kentucky residents seeking physician-supervised weight loss using semaglutide or tirzepatide, the practice offers specialized expertise in metabolic and hormonal medicine delivered through accessible telehealth platforms.